Magnet Biomedicine announced Friday it has reached a licensing agreement worth up to $1.25B with Eli Lilly (NYSE ... As part of the deal, Boston, the Massachusetts-based firm will receive up ...

Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years, including four ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The Boston biotech scene’s a mess, and Marty Makary’s and ...

The molecular glue wave that first began years ago is still swelling, with Eli Lilly earmarking approximately ... In total, the Boston-based precision medicine firm can potentially earn more ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

Series B funding secured from investors, including founder Flagship Pioneering and Eli Lilly & CompanyTwo lead programs in ...